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Objectives:	   Thrombocytopenia	   and	   splenomegaly	   are	   common	   features	   in	   several	   haematological	   disorders.	  Gaucher	  
disease	   (GD)	   is	   a	   rare	   lysosomal	   storage	   disorder	   frequently	   characterized	   by	   thrombocytopenia	   and	   splenomegaly,	  
which	  represents	  a	  clinical	  challenge	  for	  haematologists	  and	  internists.	   	  
Case:	  We	  describe	  the	  case	  of	  a	  37-­‐year-­‐old	  patient	  with	  a	  diagnosis	  of	  spherocytosis	  since	  childhood,	  who	  developed	  
hepatic	   failure	  and	  presented	   striking	   features	  of	  GD	   including	  hepatosplenomegaly,	  bone	   fractures	  and	  post-­‐partum	  
bleeding.	  We	  reconsidered	  the	  diagnosis	  of	  spherocytosis	  and	  investigated	  Gaucher	  disease.	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Case	  report	   	  
A	   37-­‐year-­‐old	   Caucasian	  woman	   presented	   to	   the	   emergency	   department	  with	   gradually	   increasing	   abdominal	   girth,	  
weight	  gain	  (3	  kg	  in	  6	  days)	  and	  swelling	  in	  the	  ankles.	  She	  complained	  fatigue	  and	  exertional	  dyspnoea.	  She	  denied	  any	  
alcohol	  use	  or	  spontaneous	  bruising.	  No	  history	  of	  liver	  diseases	  or	  hepatitis	  was	  reported.	  She	  referred	  a	  diagnosis	  of	  
spherocytosis	   for	   persistent	   anaemia	   (mean	   haemoglobin	   value	   10	   g/dl)	   with	   occasional	   blood	   transfusions,	  
thrombocytopenia	   (100,000/mm3)	   and	   hepatosplenomegaly	   at	   the	   age	   of	   3	   years.	   She	   reported	   a	   delayed	   growth	  
during	  childhood	  and	  a	  severe	  fracture	  of	  the	  left	  humerus,	  associated	  with	  humeral	  head	  necrosis,	  playing	  basketball	  
when	  she	  was	  a	  teenager.	  No	  further	  investigations	  were	  performed	  at	  that	  time.	  The	  last	  MR	  study	  was	  performed	  in	  
2009,	  demonstrating	   left	  humeral	  head	  osteonecrosis	  associated	  with	  severe	  arthrosis	  and	  fibrocystic	  dysplasia	  of	  the	  
proximal	  third	  of	  the	  diaphysis	  of	  the	  humerus.	  She	  had	  two	  pregnancies,	  at	  the	  age	  of	  30	  and	  33	  years.	  Post-­‐partum	  
bleeding	   occurred	   after	   the	   first	   delivery,	   with	   a	   need	   for	   blood	   transfusion,	   in	   the	   absence	   of	   blood	   coagulation	  
abnormalities	  and	  history	  of	  prothrombotic	  diseases.	   	  
At	  admission,	  physical	  examination	   revealed	  pallor,	  hepatosplenomegaly	   (liver	  at	  6	  cm	  and	  spleen	  at	  10	  cm	  from	  the	  
lower	   costal	   margin)	   and	   oedema	   in	   both	   legs.	   She	   was	   admitted	   to	   the	   internal	   medicine	   department	   for	   further	  
investigation.	   	  
Blood	   examination	   showed	   leukopenia	   (1,730/mm3)	  with	   reduced	  neutrophil	   count	   (1,003/mm3),	   thrombocytopenia	  
(92,000/mm3)	   and	   normochromic	   normocytic	   anaemia	   (red	   blood	   cells	   [RBC]	   2,450/mm3,	   Hb	   7.8	   g/dl,	   mean	  
corpuscular	   volume	   [MCV]	   90.1	   fl,	  mean	   corpuscular	   haemoglobin	   [MCH]	   27.4	   pg,	   red	   cell	   distribution	  width	   [RDW]	  
15.9%)	  with	  mild	   increased	   ferritin	   value	   (352	  ng/ml)	   and	  normal	   transferrin	   saturation	   and	   serum	   iron	   (21%	  and	  34	  
mcg/dl,	  respectively).	  Haemolytic	  indices,	  folates	  and	  vitamin	  B12	  were	  all	  normal.	  Because	  of	  the	  previous	  diagnosis	  of	  
spherocytosis,	   blood	   smear	   and	   osmotic	   globular	   resistance	   tests	   were	   performed,	   and	   the	   results	   were	   normal,	  
excluding	   the	   diagnosis	   of	   spherocytosis.	   Renal	   and	   liver	   function	  were	  within	   the	   normal	   limits,	   except	   for	   reduced	  
pseudocholinesterase	   (2,760	   U/l,	   normal	   range	   5,300–12,900)	   and	   hypergammaglobulinaemia	   at	   the	   protein	  
electrophoresis	  with	  immunofixation	  positive	  for	  immunoglobulin	  G	  lambda	  (0.60	  g/dl),	   increased	  beta2-­‐microglobulin	  
(4.48	   mcg/ml,	   normal	   range	   0.6–2.6)	   and	   negative	   urine	   immunofixation.	   Autoimmune,	   virological	   and	   neoplastic	  
diseases	  were	   excluded.	   Thrombophilic	   screening	  was	   repeated,	   and	   results	  were	   normal.	   JAK2-­‐V617F	  mutation	  was	  
absent.	  Testing	  for	  HFE	  mutations	  did	  not	  detect	  C282Y	  or	  H63D,	  excluding	  genetic	  haemochromatosis.	   	  
Abdominal	   ultrasound	   confirmed	   the	   splenomegaly	   (diameter	   18	   cm).	   The	   CT	   scan	   also	   documented	   a	   chronic	  
hepatosteatosis	  with	  portal	  hypertension	  (diameter	  of	  the	  portal	  vein	  18	  mm).	  Hepatic	  stiffness	  assessed	  by	  transient	  
elastometry	   (FibroScan®)	   was	   7.4	   KPa	   (normal	   value	   <5	   KPa),	   consistent	   with	   Stage	   1	   fibrosis.	  
Oesophagogastroduodenoscopy	  excluded	  oesophageal	  varices.	  Results	  of	  a	  chest	  X-­‐ray	  and	  gynaecological	  examination	  
were	  normal.	  The	  swelling	  of	  the	  ankles	  was	  completely	  solved	  with	  diuretics;	  the	  patient	  was	  transfused	  with	  2	  units	  of	  
blood.	   	  
As	  the	  haematological	  data	  ruled	  out	  a	  diagnosis	  of	  spherocytosis,	  a	  liver	  biopsy	  was	  performed.	  The	  specimen	  revealed	  
the	   presence	   of	   fibrosis	   and	   significant	   portal	   and	   lobular	   infiltration	   by	   aggregated	   polygonal	   cells	   CD68+	   with	  
cytoplasm	  including	  fibrillar	  material	  PAS+,	  without	  iron	  overload.	  These	  findings	  were	  suggestive	  of	  lysosomal	  storage	  
disorder,	  including	  Gaucher	  disease	  (GD),	  which	  was	  confirmed	  by	  increased	  chitotriosidase	  activity	  (14,290	  nmol/h/ml,	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normal	   range	   <100)	   and	   undetectable	   beta-­‐glucosidase	   activity	   (28	   nmol/h/mg,	   normal	   range	   200–500).	   The	  
beta-­‐glucosidase	   gene	   sequence	   showed	   a	   compound	   heterozygosity	   for	   N370S	   (c.1226A>G)	   and	  W184R	   (c.667T>C)	  
mutations.	  
Instrumental	   and	   clinical	   evaluation	   of	   GD	   was	   performed.	   MRI	   of	   the	  
lumbar	   spine,	   bilateral	   hips	   and	   left	   humerus	   showed	   diffuse	   marrow	  
changes	  with	  bone	  infarcts	  in	  the	  left	  humerus	  consistent	  with	  GD	  (Fig.	  1).	   	  
Endocrinological	  evaluation,	  including	  blood	  and	  urine	  tests,	  was	  normal;	  
a	  DEXA	  scan	  showed	  a	  mild	  osteopenia	  (spine	  and	  femoral	  neck	  Z-­‐scores,	  
respectively,	   of	   –1.5	   and	   –1.3).	   Lipid	   assessment	   demonstrated	   reduced	  
serum	   cholesterol	   and	   high-­‐density	   lipoprotein	   concentration,	   as	  
commonly	  observed	  in	  GD.	  Chest	  X-­‐ray	  and	  respiratory	  tests	  were	  normal.	  
Electrocardiogram	   revealed	   normal	   sinus	   rhythm	   with	   frequent	  
extrasystoles,	   not	   confirmed	   by	   24-­‐h	   ECG.	   Cardiac	   MR	   with	   gadolinium	  
contrast	  excluded	  iron	  overload	  (T2*	  28.93	  ms,	  normal	  value	  >20	  ms)	  and	  
the	   presence	   of	   glycosphingolipids	   in	   the	   myocardial	   tissue.	   Pulmonary	  
hypertension	  was	   excluded	  by	   cardiac	  MR	  and	  Doppler	   echocardiogram.	  
Neurological	   evaluation	   excluded	   abnormalities,	   including	   peripheral	  
neuronopathy,	  tremor	  and	  other	  extrapyramidal	  movement	  abnormalities	  
and	  cognitive	  dysfunction.	   	  
The	  patient	  started	  enzyme	  replacement	  therapy	  (ERT)	  in	  July	  2013	  with	  Cerezyme®	  60	  U/kg	  every	  2	  weeks,	  and	  after	  
one	  year	  of	  ERT	  the	  laboratory	  parameters	  had	  improved	  (Table	  1).	   	  
	  
	  
Variable	   Reference	  range	   At	  diagnosis	   After	  one	  year	  of	  ERT	  
Leukocytes	  (/mm3)	   4,800–10,800	   1,730	   3,000	  
Neutrophils	  (%)	   40–75	   58	   67	  
Haemoglobin	  (g/dl)	   12–16	   7.8	   12.0	  
MCV	  (fl)	   78–99	   90.1	   83.3	  
Platelets	  (/mm3)	   130,000–400,000	   92,000	   146,000	  
Serum	  iron	  (mcg/dl)	   37–145	   34	   62	  
Transferrin	  saturation	  (%)	   <45	   21	   21	  
Serum	  ferritin	  (ng/ml)	   15–150	   352	   288	  
Pseudocholinesterase	  (U/l)	   5,300–12,900	   2,764	   3,800	  
Immunoglobulin	  IgG	  lambda	  (g/dl)	   ND	   0.60	   0.40	  
Beta2-­‐microglobulin	  (mcg/ml)	   0.8–2.2	   3.4	   1.59	  
Chitotriosidase	  (nmol/h/ml)	   	   	  <100	   14,290	   3,254	  
Figure	  1:	  Coronal	  T2-­‐weighted	  sequence	  of	  the	  
proximal	  left	  humerus	  showing	  severe	  bone	  
alteration	  of	  the	  humeral	  head	  with	  decreased	  
signal	  intensity	  and	  focal	  hyperintensity	  diagnostic	  
Table	  1	  Laboratory	  data.	  ND,	  not	  detectable	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Actually,	   the	   patient	   is	  well	   and	   she	   is	   still	   receiving	   ERT.	   No	   side	   effects	   have	   occurred,	   and	   her	   compliance	   to	   the	  
therapy	  is	  satisfactory.	  
	  
Discussion	  
Anaemia	   and	   splenomegaly	   are	   common	   manifestations	   of	   several	   haematologic	   diseases,	   including	   haemolytic	  
anaemias,	  thalassaemia	  and	  some	  lysosomal	  storage	  disorders	  such	  as	  GD.	  GD	  is	  the	  most	  common	  autosomal	  recessive	  
lysosomal	   storage	   disorder,	   which	   is	   caused	   by	   a	   deficiency	   of	   the	   enzyme	   glucocerebrosidase	   responsible	   for	   the	  
accumulation	   of	   glucosylceramide	   (glucocerebroside)	   in	   the	   reticuloendothelial	   cells	   of	   the	   liver,	   spleen	   and	   bone	  
marrow	  [1].	  More	  than	  350	  mutations	  in	  the	  glucocerebrosidase	  gene	  (GBA)	  have	  been	  reported,	  with	  frequencies	  that	  
vary	  by	  ethnicity	  and	  disease	  type,	   leading	  to	  heterogeneous	  presentations	  and	  manifestations	  with	  often	  uncommon	  
features.	   GD	   is	   a	   complex	   and	   systemic	   disease	   representing	   a	   real	   challenge	   for	   internists	   and	   haematologists	   [2].	  
Splenomegaly	   and/or	   thrombocytopenia	   are	   the	  most	   common	  presenting	   features,	   but	  other	   clinical	  manifestations	  
include	   hepatomegaly,	   bone	   pain	   with	   skeletal	   complications,	   bleeding	   diathesis,	   pulmonary	   hypertension	   and	  
neurological	  manifestations	   [3].	   ERT	   is	  available	  and	  proved	   to	  be	   safe	  and	  effective	   in	   reversing	  or	  preventing	  many	  
manifestations	  [4].	  
Starting	  from	  a	  simple	  diagnostic	  algorithm	  proposed	  by	  Mistry	  et	  al.	  [5],	   it	   is	  possible	  to	  correctly	  diagnose	  GD	  in	  the	  
presence	   of	   splenomegaly	   and/or	   thrombocytopenia.	   This	   approach	   is	   extremely	   useful	   to	   avoid	  
misdiagnosis/underdiagnosis	  and	  diagnostic	  delays,	   	   in	  order	  to	  start	  ERT,	  which	  can	  prevent	  severe	  organ	  damage.	  In	  
our	  case,	  the	  correct	  diagnosis	  was	  made	  at	  the	  age	  of	  37	  years.	  Signs	  and	  symptoms	  had	  been	  present	  since	  the	  age	  of	  




• Although	   rare,	   Gaucher	   disease	   should	   be	   taken	   into	   consideration	   in	   differential	   diagnosis	   of	   splenomegaly	  
and/or	  thrombocytopenia.	  
• Accumulation	  of	  glucocerebroside	  can	  occur	  in	  several	  organs	  (bone	  marrow,	  spleen,	  liver,	  skeleton,	  and	  rarely	  
lungs	  and	  central	  nervous	  system),	   leading	  to	  multiorgan	  damage	  and	  clinical	  complications	  that	  may	  mislead	  
the	  diagnosis.	  
• Early	  diagnosis	  is	  extremely	  important	  because	  ERT	  is	  effective	  in	  preventing	  or	  reversing	  many	  manifestations,	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